Pituitary & hypothalamus

Patients with langerhans cell histiocytosis and hypothalamic-pituitary involvement: insights from the HEROS study cohort

PituitaryPublished Multicentre observational cohort study

An erratum to this article was published (Pituitary, 25 Mar 2026 ↗)

Authors' conclusion

Patients with LCH and hypothalamic-pituitary involvement remained clinically stable during long-term follow-up. However, new hormonal deficits may develop years after diagnosis, with most patients ultimately experiencing AVD.

Study context

Population
Patients with Langerhans cell histiocytosis (LCH) and hypothalamic-pituitary involvement, included by European NeuroEndocrine Association (ENEA) members58% males
Participants
48 patients
Outcome
Hormonal deficiencies at diagnosis
Follow-up
At diagnosis
Methodological detailsmulticenter, HEROS platform
  • Multicenter
  • HEROS platform

Main finding

As reported in the abstract

AVP deficiency (arginine vasopressin deficiency (AVD))
69%
Central hypogonadism
42%
Hypothyroidism
25%
Hypocortisolism
12.5%
Posterior pituitary/pituitary stalk pathology on magnetic resonance imaging (MRI) (41 with MRI)
73%

Observational data: associations, not effects.

Further findings

Presentation at diagnosis

Initial presentation with bone lesions
46%
Initial presentation with lung involvement
42%
Incidentally diagnosed
5 patients
Visual disturbances
1 patient

MRI findings

MRI available
41 patients
Pathology of posterior pituitary/pituitary stalk
73%

Course during follow-up · mean follow-up 15.8 ± 10.6 years

Developed new AVD
27%
Acquired new anterior pituitary hormone deficiency
5 patients
There was no disease-related mortality during follow-up

Diagnostic procedures

Histopathological confirmation, mainly from extra-pituitary lesions
all patients
Transcranial biopsy
5 patients
Transsphenoidal intervention
2 patients

Original publication

Patients with langerhans cell histiocytosis and hypothalamic-pituitary involvement: insights from the HEROS study cohort. Pituitary. Published 26 September 2025. doi:10.1007/s11102-025-01576-3

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.